三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
图23RC18组和安慰剂组的ACR20应答率比较
图23RC18组和安慰剂组的ACR20应答率比较
其它
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:372KB
图片尺寸:1770*1046
同报告图片
/
4
fCBXZWVrIHwgMTYwIG1nIHwgUGxhY2VibyB8CnwtLS0tLS18LS0tLS0tLS18LS0tLS0tLS0tfAp8IDAgICAgfCAwJSAgICAgfCAwJSAgICAgIHwKfCA0ICAgIHwgMTYuMSUgIHwgNC4yJSAgICB8CnwgOCAgICB8IDMxLjQlICB8IDEwLjklICAgfAp8IDEyICAgfCAzOS40JSAgfCAxNy42JSAgIHwKfCAxNiAgIHwgNDguMSUgIHwgMTkuMyUgICB8CnwgMjAgICB8IDU1LjMlICB8IDI0LjQlICAgfAp8IDI0ICAgfCA2MC4wJSAgfCAyNi45JSAgIHwKCui1hOaWmeadpea6kO+8muiNo+aYjOeUn+eJqeW+ruS/oeWFrOS8l+WPt++8jOS4nOa1t+ivgeWIuOeglOeptuaJgA==
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
所属报告:
荣昌生物-公司深度报告:核心产品快速放量新适应症加速推进-240619(41页).pdf
打包全文图表
相关数据
Ph3ORIGIN3研究中Atacicept及安慰剂组受试者第36周uPCR及Gd-IgA1数据
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
收藏
行业数据
2026-03-13
原图定位
查看详情
VOR正在推进的RC18海外临床情况
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
收藏
行业数据
2026-03-13
原图定位
查看详情
RC18计划启动的6大适应症情况
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
收藏
行业数据
2026-03-13
原图定位
查看详情
RC18对比其他药物针对MG的疗效情况
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
收藏
行业数据
2026-03-13
原图定位
查看详情
RC18针对SDESSDAI剔除安慰剂评分下降情况对比其他药物
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
收藏
行业数据
2026-03-13
原图定位
查看详情
地达西尼安全性和安慰剂相当
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
收藏
行业数据
2025-11-24
原图定位
查看详情
部分口服GLP-1类药物的减重效果对比(安慰剂矫正)
fCDoja/nianlkI3np7AgICAgICAgICAgICAgICAgICB8IOayu+eWl+aXtumXtO+8iOWRqO+8iSB8IOWuieaFsOWJguefq+ato+WQjuS9k+mHjemZjeW5he+8iCXvvIkgfAp8LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCBIUlM5NTMx54mHICAgICAgICAgICAgICAgICB8IDQgICAgICAgICAgICAgIHwgLTMuNTAgICAgICAgICAgICAgICAgICAgICAgfAp8IENULTk5NiAgICAgICAgICAgICAgICAgICAgfCA0ICAgICAgICAgICAgICB8IC02LjEwICAgICAgICAgICAgICAgICAgICAgIHwKfCBBU0MzMCAgICAgICAgICAgICAgICAgICAgIHwgNCAgICAgICAgICAgICAgfCAtNi41MCAgICAgICAgICAgICAgICAgICAgICB8CnwgUkdULTA3NSAgICAgICAgICAgICAgICAgICB8IDEyICAgICAgICAgICAgIHwgLTQuOTUgICAgICAgICAgICAgICAgICAgICAgfAp8IENvbnZlZ0lpcHJvbiAgICAgICAgICAgICAgfCAxMiAgICAgICAgICAgICB8IC01LjU5ICAgICAgICAgICAgICAgICAgICAgIHwKfCBWSzI3MzUob3JhbCkgICAgICAgICAgICAgIHwgMTMgICAgICAgICAgICAgfCAtMTAuOTAgICAgICAgICAgICAgICAgICAgICB8CnwgQW15Y3JldGluLU5OOTQ4NyAgICAgICAgICB8IDEyICAgICAgICAgICAgIHwgLTExLjkwICAgICAgICAgICAgICAgICAgICAgfAp8IEhSUy03NTM1ICAgICAgICAgICAgICAgICAgfCAzNiAgICAgICAgICAgICB8IC04LjEwICAgICAgICAgICAgICAgICAgICAgIHwKfCBSZXRhdHJ1dGlkZSAoMTJtZykgICAgICAgIHwgNDggICAgICAgICAgICAgfCAtMjIuMSAgICAgICAgICAgICAgICAgICAgICB8Cnwg5Y+4576O5qC86bKB6IK9LzI1bWcgICAgICAgICAgIHwgNjQgICAgICAgICAgICAgfCAtMTEuNDAgICAgICAgICAgICAgICAgICAgICB8CnwgT3Jmb3JnbGlwcm9uICAgICAgICAgICAgICB8IDcyICAgICAgICAgICAgIHwgLTEyLjQwICAgICAgICAgICAgICAgICAgICAgfAp8IOivuuWSjOivuuW+ty/lj7jnvo7moLzpsoHogr0gKDIuNG1nKXwgNjggICAgICAgICAgICAgfCAtMTIuOCAgICAgICAgICAgICAgICAgICAgICB8Cnwg5pu/5bCU5rOK6IK9ICgxNW1nKSAgICAgICAgICAgfCA3MiAgICAgICAgICAgICB8IC0xOC43ICAgICAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWQhOWFrOWPuOWFrOWRiu+8jOWbvemHkeivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-11-19
原图定位
查看详情
GLP-1RA±amylin类疗法减重效果对比(安慰剂矫正)
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
收藏
行业数据
2025-11-19
原图定位
查看详情
部分GIP-1/GIPR/GCGR靶点药物的减重效果对比(安慰剂矫正)
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
收藏
行业数据
2025-11-19
原图定位
查看详情
图表44校正安慰剂影响后载脂蛋白B变化情况
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
收藏
行业数据
2025-09-28
原图定位
查看详情
Lp(a)抑制剂的疗效:校正安慰剂效应后的Lp(a)变化百分比
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
收藏
行业数据
2025-09-28
原图定位
查看详情
图表43校正安慰剂影响后Lp(a)变化情况
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
收藏
行业数据
2025-09-28
原图定位
查看详情
Lp(a)抑制剂的疗效:校正安慰剂效应后的LDL变化百分比
fCDoja/nianlkI3np7AgICAgICAgfCDliYLph4/lj4rnu5noja/popHnjocgICB8IExETOWPmOWMlueZvuWIhuavlO+8iCXvvIkgfAp8LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS18CnwgT2xwYXNpcmFuICAgICAgfCAyMjVtZyBRMTJXICAgICAgIHwgLTIzICAgICAgICAgICAgICAgIHwKfCBNdXZhbGFwbGluICAgICB8IDI0MG1nIFFEICAgICAgICAgfCAtMjIgICAgICAgICAgICAgICAgfAp8IFplcmxhc2lyYW4gICAgIHwgMzAwbWcgUTE2VyAgICAgICB8IC0zMCAgICAgICAgICAgICAgICB8CnwgUGVsYWNhcnNlbiAgICAgfCAyMG1nIFFXICAgICAgICAgIHwgLTE5ICAgICAgICAgICAgICAgIHwKfCBPYmljZXRyYXBpYiAgICB8IDEwbWcgUUQgICAgICAgICAgfCAtMjkgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5ZCE5YWs5Y+45YWs5ZGK77yM5Y2O5rOw56CU56m2
收藏
行业数据
2025-09-28
原图定位
查看详情
nemolizumab2期临床数据显示,12周瘙痒改善情况优异,且1周时较安慰剂改善超20%
IyMjIOihqDHvvJoxMuWRqOeYmeeXkuivhOWIhueZvuWIhuavlOWPmOWMliAgCnwg57uE5YirICAgICAgICAgICAgICAgICAgICAgfCDmoLfmnKzph4/vvIhO77yJIHwgMTLlkajnmJnnl5Lor4TliIbnmb7liIbmr5Tlj5jljJYgfCAgCnwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwgIAp8IFBsYWNlYm8gICAgICAgICAgICAgICAgICB8IDI2ICAgICAgICAgIHwgLTIwLjkgICAgICAgICAgICAgICAgICB8ICAKfCBOZW1vbGl6dW1hYiAwLjEgbWcva2cgICAgfCAzMyAgICAgICAgICB8IC00My43ICAgICAgICAgICAgICAgICAgfCAgCnwgTmVtb2xpenVtYWIgMC41IG1nL2tnICAgIHwgMzUgICAgICAgICAgfCAtNTkuOCAgICAgICAgICAgICAgICAgIHwgIAp8IE5lbW9saXp1bWFiIDIuMCBtZy9rZyAgICB8IDMyICAgICAgICAgIHwgLTYzLjEgICAgICAgICAgICAgICAgICB8ICAKCgojIyMg6KGoMu+8muavj+WRqOWkhOS6jumjjumZqeeahOS6uuaVsO+8iE5vLiBhdCBSaXNr77yJICAKfCDlkajvvIhXZWVr77yJIHwg5a6J5oWw5YmC77yIUGxhY2Vib++8iSB8IE5lbW9saXp1bWFiIDAuMSBtZy9rZyB8IE5lbW9saXp1bWFiIDAuNSBtZy9rZyB8IE5lbW9saXp1bWFiIDIuMCBtZy9rZyB8ICAKfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tfCAgCnwgMCAgICAgICAgICB8IDUzICAgICAgICAgICAgICAgIHwgNTMgICAgICAgICAgICAgICAgICAgIHwgNTQgICAgICAgICAgICAgICAgICAgIHwgNTIgICAgICAgICAgICAgICAgICAgIHwgIAp8IDEgICAgICAgICAgfCA1MiAgICAgICAgICAgICAgICB8IDUzICAgICAgICAgICAgICAgICAgICB8IDU0ICAgICAgICAgICAgICAgICAgICB8IDUxICAgICAgICAgICAgICAgICAgICB8ICAKfCAyICAgICAgICAgIHwgNDkgICAgICAgICAgICAgICAgfCA1MyAgICAgICAgICAgICAgICAgICAgfCA1NCAgICAgICAgICAgICAgICAgICAgfCA1MSAgICAgICAgICAgICAgICAgICAgfCAgCnwgMyAgICAgICAgICB8IDQ3ICAgICAgICAgICAgICAgIHwgNTAgICAgICAgICAgICAgICAgICAgIHwgNTIgICAgICAgICAgICAgICAgICAgIHwgNDkgICAgICAgICAgICAgICAgICAgIHwgIAp8IDQgICAgICAgICAgfCA0NSAgICAgICAgICAgICAgICB8IDQ5ICAgICAgICAgICAgICAgICAgICB8IDUxICAgICAgICAgICAgICAgICAgICB8IDQ4ICAgICAgICAgICAgICAgICAgICB8ICAKfCA1ICAgICAgICAgIHwgMzUgICAgICAgICAgICAgICAgfCA0NiAgICAgICAgICAgICAgICAgICAgfCA0NyAgICAgICAgICAgICAgICAgICAgfCA0NiAgICAgICAgICAgICAgICAgICAgfCAgCnwgNiAgICAgICAgICB8IDM1ICAgICAgICAgICAgICAgIHwgNDYgICAgICAgICAgICAgICAgICAgIHwgNDQgICAgICAgICAgICAgICAgICAgIHwgNDMgICAgICAgICAgICAgICAgICAgIHwgIAp8IDcgICAgICAgICAgfCAzMyAgICAgICAgICAgICAgICB8IDQwICAgICAgICAgICAgICAgICAgICB8IDQwICAgICAgICAgICAgICAgICAgICB8IDQwICAgICAgICAgICAgICAgICAgICB8ICAKfCA4ICAgICAgICAgIHwgMzEgICAgICAgICAgICAgICAgfCA0MCAgICAgICAgICAgICAgICAgICAgfCAzNyAgICAgICAgICAgICAgICAgICAgfCAzNyAgICAgICAgICAgICAgICAgICAgfCAgCnwgOSAgICAgICAgICB8IDI2ICAgICAgICAgICAgICAgIHwgMzYgICAgICAgICAgICAgICAgICAgIHwgMzYgICAgICAgICAgICAgICAgICAgIHwgMzYgICAgICAgICAgICAgICAgICAgIHwgIAp8IDEwICAgICAgICAgfCAyNSAgICAgICAgICAgICAgICB8IDM0ICAgICAgICAgICAgICAgICAgICB8IDM2ICAgICAgICAgICAgICAgICAgICB8IDM0ICAgICAgICAgICAgICAgICAgICB8ICAKfCAxMSAgICAgICAgIHwgMjYgICAgICAgICAgICAgICAgfCAzMyAgICAgICAgICAgICAgICAgICAgfCAzNiAgICAgICAgICAgICAgICAgICAgfCAzMyAgICAgICAgICAgICAgICAgICAgfCAgCnwgMTIgICAgICAgICB8IDI2ICAgICAgICAgICAgICAgIHwgMzMgICAgICAgICAgICAgICAgICAgIHwgMzUgICAgICAgICAgICAgICAgICAgIHwgMzIgICAgICAgICAgICAgICAgICAgIHwgIAoKCiMjIyDotYTmlpnmnaXmupAgIArjgIpBbnRp4oCTSW50ZXJsZXVraW7igJMzMSBSZWNlcHRvciBBIEFudGlib2R5IGZvciBBdG9waWMgRGVybWF0aXRpc+OAi++8jOWbvemHkeivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-09-17
原图定位
查看详情
nemolizumab2期临床数据显示,12周瘙痒改善情况优异,且1周时较安慰剂改善超20%
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
收藏
行业数据
2025-09-17
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
RC18 治疗 RA 具有较好的疗效和安全性。2023 年 11 月 15 日,公司在美国风湿病学会(ACR)年会上公布了泰它西普治疗 RA 的Ⅲ期临床试验结果。数据显示,24 周时,与安慰剂组相比,泰它西普组 ACR20 应答率显著增加(60.0% vs 26.9%,P<0.001)。在第 24周,泰它西普组的 ACR50 应答率显著高于安慰剂组(21.4%vs.5.9%,P<0.001),并且在DAS28-ESR 较基线降低以及 ACR 应答标准的各个组成部分方面,均显著优于安慰剂组。此外,泰它西普组在第 24 周无放射性学进展(△mTSS≤0)的患者比例显著高于安慰剂组(90.2% vs 66.4%,P<0.001)。与基线相比,泰它西普组的患者关节损伤进展(根据 mTSS、关节间隙狭窄评分和侵蚀评分)在第 24 周时显著减少。安全性方面,泰它西普组与安慰剂组在治疗相关不良事件(TEAEs)、严重不良事件(SAEs)、导致停止研究治疗的 TEAEs 以及感染发生率方面相似,研究期间未见死亡事件。2023 年 9 月 10 日,RC18 的上市申请获CDE 受理,预计 2024 年获批上市。
其它
原图定位
当前图表所属:
荣昌生物-公司深度报告:核心产品快速放量新适应症加速推进-240619(41页).pdf
表9全球进入III期及以上阶段的IgA肾病创新药
表8美国及中国已上市治疗RA的创新生物药
表7RC18治疗SLE的不良反应数据
表6国内外已上市和部分在研的SLE适应症的创新生物药
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》